More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Political uncertainty in some of the largest European economies has diminished their growth outlook. Read more here.
Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...
A new study has found that semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with AUD. Despite the availability of treatment options ...
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...